Supernus Pharmaceuticals | SUPN - Umlaufvermögen

Aktienkurs
49.29
Täglich Wechseln
-1.53 -3.01%
Monatlich
-4.01%
Jährlich
53.89%
Q1 Prognose
48.40




Umlaufvermögen Veränderung Datum
Abbott USD 26B 1.16B 2025-12
ANI Pharmaceuticals USD 753.12M 54.72M 2025-12
Aurora Cannabis CAD 423.84M 41.46M 2025-09
Bristol-Myers Squibb USD 35.63B 2.41B 2025-09
Canopy Growth CAD 445.82M 142.46M 2025-09
Cara Therapeutics USD 43.13M 4.18M 2025-06
Corcept Therapeutics USD 485.46M 55.67M 2025-12
Eisai JPY 840.88B 50.18B 2025-12
Eli Lilly USD 55.63B 6.44B 2025-12
Novo Nordisk DKK 172.45B 9.43B 2025-12
Pacira USD 547.97M 14.78M 2025-12
Perrigo USD 2.8B 81.8M 2025-12
Pfizer USD 46.92B 3.22B 2025-09
Supernus Pharmaceuticals USD 644.18M 50.29M 2025-12
United Therapeutics USD 3.7B 208.5M 2025-12
Xeris Pharmaceuticals USD 224.02M 38.44M 2025-09